Cardiopulmonary Testing in ME/CFS to Improve Diagnostic Accuracy

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02970240
• Date of registration: 14/11/2016
• Prospective Registration: No
• Primary sponsor: University of Oslo
• Public title: Cardiopulmonary Testing in ME/CFS to Improve Diagnostic Accuracy
• Scientific title: Cardiopulmonary Exercise Testing as a Diagnostic Tool and a Quantitative Measure of Post-exertional Malaise in Myalgic Encephalopathy/Chronic Fatigue Syndrome
• Date of first enrolment: June 2014
• Target sample size: 33
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02970240
• Study type: Observational

Countries of recruitment

Norway

Contacts

• Name: Per O Iversen, MD
• Affiliation: University of Oslo

Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosed with ME/CFS according to the Canadian and Fukuda criteria; miid to
moderately affected)

- Provide written consent

- Able to perform the test

Exclusion Criteria:

- Not provided written consent

- Unable to perform the test



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Myalgic Encephalomyelitis

Chronic Fatigue Syndrome

Intervention(s)

Procedure: Cardiopulmonary testing

Primary Outcome(s)

Maximal oxygen uptake [Time Frame: At 48 hour]

Secondary Outcome(s)

Lactate accumulation [Time Frame: At 48 hour]

Cardiac status [Time Frame: At 48 hour]

Immunophenotyping [Time Frame: At 48 hour]

Cytokine profile [Time Frame: At 48 hour]

Secondary ID(s)

2012/571

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Oslo University Hospital

The Glittre Clinic